1. Home
  2. SAGE vs LGTY Comparison

SAGE vs LGTY Comparison

Compare SAGE & LGTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • LGTY
  • Stock Information
  • Founded
  • SAGE 2010
  • LGTY 1970
  • Country
  • SAGE United States
  • LGTY United States
  • Employees
  • SAGE N/A
  • LGTY 389
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • LGTY
  • Sector
  • SAGE Health Care
  • LGTY
  • Exchange
  • SAGE Nasdaq
  • LGTY NYSE
  • Market Cap
  • SAGE 474.6M
  • LGTY 506.9M
  • IPO Year
  • SAGE 2014
  • LGTY N/A
  • Fundamental
  • Price
  • SAGE $7.37
  • LGTY $14.28
  • Analyst Decision
  • SAGE Hold
  • LGTY Hold
  • Analyst Count
  • SAGE 19
  • LGTY 1
  • Target Price
  • SAGE $9.88
  • LGTY N/A
  • AVG Volume (30 Days)
  • SAGE 1.2M
  • LGTY 613.9K
  • Earning Date
  • SAGE 04-24-2025
  • LGTY 02-20-2025
  • Dividend Yield
  • SAGE N/A
  • LGTY 3.08%
  • EPS Growth
  • SAGE N/A
  • LGTY N/A
  • EPS
  • SAGE N/A
  • LGTY N/A
  • Revenue
  • SAGE $41,243,000.00
  • LGTY $101,873,000.00
  • Revenue This Year
  • SAGE $100.39
  • LGTY $2.14
  • Revenue Next Year
  • SAGE $70.86
  • LGTY $3.93
  • P/E Ratio
  • SAGE N/A
  • LGTY N/A
  • Revenue Growth
  • SAGE N/A
  • LGTY N/A
  • 52 Week Low
  • SAGE $4.62
  • LGTY $8.41
  • 52 Week High
  • SAGE $17.51
  • LGTY $14.29
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 40.58
  • LGTY N/A
  • Support Level
  • SAGE $7.99
  • LGTY N/A
  • Resistance Level
  • SAGE $7.97
  • LGTY N/A
  • Average True Range (ATR)
  • SAGE 0.31
  • LGTY 0.00
  • MACD
  • SAGE -0.10
  • LGTY 0.00
  • Stochastic Oscillator
  • SAGE 1.37
  • LGTY 0.00

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About LGTY LOGILITY SUPPLY CHAIN SOLUTIONS INC

Logility Supply Chain Solutions Inc develops enterprise management and supply chain-related software and services. Its Services include Scenario Planning Products, Demand Planning InventoryAI+, Supply, Deployment, Supply Chain Data Management, and Supply Chain Design. The group provides services to various industries such as Food and Beverage Consumer Packaged Goods, Process Manufacturing, Industrial Manufacturing, Chemicals, and others.

Share on Social Networks: